Population impact of strategies designed to reduce peptic ulcer risks associated with NSAID use

International Journal of Clinical Practice, Supplement

Volumn , Issue 135, 2003, Pages 38-42

  Langman, Michael ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZAPROPAZONE; DICLOFENAC; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

CONFERENCE PAPER; DRUG SAFETY; DRUG USE; DRUG UTILIZATION; GASTROINTESTINAL HEMORRHAGE; HUMAN; INCIDENCE; LOW DRUG DOSE; MORBIDITY; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; RISK FACTOR; UNITED KINGDOM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; GREAT BRITAIN; HUMANS; INCIDENCE; PEPTIC ULCER HEMORRHAGE; RISK FACTORS;

EID: 0037395095     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Langman MJS, Weil J, Wainwright P et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-1078.
2. Rockall TA, Logan RFA, Devlin HV, Northfield TC. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. BMJ 1995; 311: 222-226.
3. Langman MJS. Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden? Pharmacoepidemiol Drug Safety 2001; 10: 13-19.
4. Forrest JB, Camu F, Greer LA et al. Ketorolac, diclofenac and ketoprofen are equally safe for pain relief after major surgery. Br J Anaesth 2002;88:227-233.
5. Weil J, Colin Jones D, Langman MJS et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995; 301: 827-830.
6. Derry S, Loke KY. Risk of gastrointestinal haemorrhage with long-term use of aspirin: meta-analysis. BMJ 2000; 321: 1183-1187.
7. Weil J, Langman MJS, Wainwright P et al. Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut 2000; 46: 27-34.